Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs
Dec. 12, 2016—"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences.
Oct. 13, 2016—Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.
Oct. 6, 2016—The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.
Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.
Mar. 10, 2016—J. David Sweatt, Ph.D., the Evelyn F. McKnight Endowed Chair of the Department of Neurobiology, director of the Civitan International Research Center, and director of the McKnight Brain Institute at the University of Alabama, Birmingham, has been named chair of Vanderbilt’s Department of Pharmacology.
Mar. 3, 2016—Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.
Dec. 10, 2015—Vanderbilt University Medical Center and Ono Pharmaceutical Group, an international company based in Japan, have signed a drug discovery agreement.
Mar. 19, 2015—From left, Joshua Fessel, M.D., Ph.D., assistant professor of Medicine, Pharmacology and Cancer Biology, receives the 2015 Pharmacology Teaching Award from first-year Pharmacology graduate students Brian Bender, Blake Dieckmann and Stephanie Moore during last week’s 24th annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall. (Photo by Steve Green)
Jan. 29, 2015—The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.